Cite
The effect of a pre-existing non alcoholic fatty liver disease on the iver toxicity of the proteasome inhibitor bortezomib
MLA
Neubert, Sebastian. The Effect of a Pre-Existing Non Alcoholic Fatty Liver Disease on the Iver Toxicity of the Proteasome Inhibitor Bortezomib. Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2091..f683c049fdb5c76efb02046e57eaa78e&authtype=sso&custid=ns315887.
APA
Neubert, S. (2023). The effect of a pre-existing non alcoholic fatty liver disease on the iver toxicity of the proteasome inhibitor bortezomib.
Chicago
Neubert, Sebastian. 2023. “The Effect of a Pre-Existing Non Alcoholic Fatty Liver Disease on the Iver Toxicity of the Proteasome Inhibitor Bortezomib,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2091..f683c049fdb5c76efb02046e57eaa78e&authtype=sso&custid=ns315887.